| |OCTOBER 20235CIOReviewIN MY OPINIONEnsuring Supply Availability Begins with Robust Supplier Quality Management Imelda Leslie Rillon, Director, Regional Quality Assurance,Zuellig Pharma30CXO INSIGHTSFacilitating a Lessons Learned Session with your CMOYvonne Ware, Associate Director, Manufacturing Operations,BioNTech18A Glimpse into the Future of Rare Diseases Drug Development: The Latest Advances and InnovationsSafwan Kezbor, M.D. Senior Medical Director, Clinical Development at Shionogi16Flexibility to Change is the Key to Successful Pharma ProjectsCarrie Lewis, Executive Director, Clinical Program Optimization,Endo Pharmaceuticals 24Complexities in the Development Process for Pharmaceutical ManufacturingErik Lemay, Head of Global External Manufacturing, Servier26Expanding the Promise of Immunotherapy Beyond the Oncology RealmJames Riddle, MCSE, CIP, CPIA, CRQM, Vice President, Research Services & Strategic Consulting,Advarra08The Vital Intersection of Academia, Biotech, and Pharma in Producing Medical TherapiesSteven Cohen, Executive Director, Translational Medicine-Oncology & Internal Medicine, & Business Development-IM, Daiichi Sankyo, Inc.21The Next Challenge of Oncology Innovation: Meeting the Needs of ProvidersDana Edwards,Vice President, Patient Access and Strategic Engagement,UBC28LAST WORD
< Page 4 | Page 6 >